⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘Hemorrhagic vasculitis✘Alport syndrome
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 100%(1)46%(3)
General urine test 62%(4)75%(14)
Blood biochemistry 11%(3)100%(2)
General blood test 11%(1)52%(8)
Ophthalmologist's examination —39%(0)
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 47%—
Register, to see more distinctive signs of diseases and studies —91%
petechiae 51% 8%
chronic kidney failure — 62%
red dots 49% 7%
kidney failure — 60%
red rash 47% 6%
hearing impaired — 58%
small-point rash 46% 7%
inflammation of the kidneys 10% 63%
skin spots 36% —
congestive kidney — 53%
rheumatism 31% —
hematuria 9% 57%
consequences of suppression 29% —
alport syndrome — 45%
skin problems 31% 12%
diffuse toxic goiter — 31%
hemorrhagic vasculitis 28% 9%
thyrotoxicosis — 31%
dic syndrome 15% —
impaired kidney function 16% 46%
erythrocytic cylindruria 15% —
enlargement of the thyroid gland — 29%
need for chocolate 15% —
microhematuria — 27%
prurigo 14% —
anemia — 27%
papular urticaria 14% —
berger 's disease — 23%
wandering rashes 14% —
proteinuria 9% 29%
hemorrhages on the skin 14% —
little urine — 20%
joint pain wandering 14% —
number of miscarriages is increased — 19%
pain in large joints 13% —
history of surgery — 19%
rash on the buttocks 13% —
antineutrophilic cytoplasmic antibodies — 17%
hemorrhagic diathesis 13% —
heaviness in the kidneys — 17%
cylindruria 13% —
deafness — 17%
rashes symmetrical 12% —
kidney damage — 17%
the Mantoux reaction 12% —
protein c deficiency — 17%
rashes bubbles 12% —
urine erythrocytes are elevated — 17%
obesity on the stomach 12% —
clouding of the lens — 17%
wandering pains 12% —
hematuric nephritis — 16%
there's a lot lying around 12% —
pale palate — 16%
consequences of injuries 12% —
end-stage renal failure — 16%
uremia 11% —
glomerulonephritis 12% 27%
fecal vomiting 11% —
fine-grained — 15%
fat deposits 11% —
sensorineural — 15%
blood in feces 11% —
increased — 15%
rash on the torso 11% —
hypertension — 15%
hypercoagulation syndrome 11% —
miscarriage — 14%
rash on the limbs 11% —
nephropathy 9% 23%
decrease in gamma globulins 11% —
visual impairment — 14%
vomiting with blood 10% —
distortion of vision — 14%
brown pigmentation after rashes 10% —
cataract — 14%
refuses to help 10% —
urolithiasis — 13%
brown spots on the skin 10% —
s eyes cloudy — 13%
intestinal bleeding 10% —
bronchitis in childhood — 13%
vaccination 10% —
dislocation of the lens — 13%
peptic ulcer 9% —
the onset of the disease during puberty — 13%
papules 9% —
aslo is reduced — 13%
does not tolerate pain 9% —
impaired arterial function — 13%
joint pain 9% —
esophageal cancer — 13%
constant pain 9% —
cloudy urine — 13%
painful appearance 9% —
onset of illness — 13%
weakening of immunity 9% —
chronic kidney disease 10% 23%
protein reduced 9% —
childhood diseases — 12%
pain in the intestines 9% —
pain in the eyes — 12%
subacute condition 8% —
abdominal pain in children — 12%
immunodeficiency 8% —
oncology — 12%
helps others 8% —
consequences of miscarriage — 12%
soreness of the skin 8% —
dyspnea — 12%
acute condition 8% —
esophageal stenosis — 12%
up circulatory disorders 8% —
antinuclear factor — 12%
consequences of infection 8% —
pain in the esophagus — 12%
drug disease 8% —
weakness of the eyes — 11%
necrosis 8% —
sediment urine — 11%
bleeding 14% 5%
kidney transplantation — 11%
joint diseases 12% 6%
convulsions — 11%
rapidly progressive glomerulonephritis — 11%
cancer — 11%
multiple kidney stones — 11%
cyclic vomiting — 11%
mucous membranes are pale — 11%
sagging skin — 11%
exophthalmos — 11%
feeling of pressure on the bottom — 11%
periodic abdominal pain — 11%
orbital hypertelorism — 11%
oxalaturia — 11%
nephritic syndrome — 11%
often abdominal pain — 11%
tumour in the abdomen — 10%
shortness of breath constant — 10%
insensitivity to pain — 10%
changes in urine — 10%
cancer in the anamnesis — 10%
Chronical bronchitis — 10%
streptodermia — 10%
death of a loved — 10%
crystalluria — 10%
dislocation — 10%
weakness in the extremities — 10%
pain in the sternum — 10%
nose large eyes — 10%
death of relatives — 10%
urination disorder — 10%
erythrocytosis — 10%
red blood vessels of the eyes — 10%
abdominal pain with vomiting — 10%
j42 chronic bronchitis — 10%
can not breathe — 10%
vomiting multiple — 10%
leukocyturia — 10%
angiopathy of the retina — 10%
ureteral stones — 10%
hemarthrosis — 9%
painful swelling — 9%
stomach pain — 9%
muscle hypertonus — 9%
feeling of cold in the body — 9%
essential hypertension — 9%
frequent colds — 9%
bronchial lesion — 9%
renal osteodystrophy — 9%
pain when breathing — 9%
up vascular mesh — 9%
tremor — 9%
oncology in the anamnesis — 9%
difficult to swallow — 9%
bronchitis — 9%
acute abdomen — 9%
urolithiasis in children — 9%
cramps in the legs — 9%
difficulty breathing — 9%
acute bronchitis — 9%
tumors of the ureter — 9%
pale skin — 9%
kidney failure in children — 9%
blurred vision — 9%
erysipelas — 8%
pyoderma — 8%
abdominal pain — 8%
scarlet — 8%
spasm — 8%
acute arthritis — 8%
body is cold — 8%
redness of the joints — 8%
human thermometer — 8%
antinuclear antibodies — 8%
weakness after illness — 8%
lags behind in the development — 8%
impaired gastric function — 8%
muscle weakness — 8%
kidney cyst — 8%

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.